Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Charles River Laboratories Intl. Inc (CRL) vs Walt Disney Co (DIS) Price & Performance

Charles River Laboratories Intl. IncTrade
Walt Disney CoTrade

Price performance (Past 24H)

Key statistics

Charles River Laboratories Intl. Inc vs Walt Disney Co — how do they compare? Charles River Laboratories Intl. Inc trades at $227.69 (market cap $11.14B), while Walt Disney Co trades at $97.42 (market cap $166.48B). The key difference: Walt Disney Co is far larger — about 14.9× Charles River Laboratories Intl. Inc's market cap, and Walt Disney Co pays a 1.56% dividend while Charles River Laboratories Intl. Inc pays none. Which is the better fit depends on your goals.

CRLDIS
Market Cap
$11.14B$166.48B
Sector
HealthMedia
52-Week High
$233.60$122.94
52-Week Low
$145.57$92.40
Enterprise Value
$14.00B$208.16B
Volume
7,546,013
Dividend Yield
1.56%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Charles River Laboratories Intl. Inc

Charles River Laboratories (CRL) trades at $229.75, down 1.57% on the day, near its consensus price target of $229.80. The stock shows a bullish technical trend with strong moving average signals and support at $225. Fundamentally, CRL has beaten EPS estimates for three consecutive quarters but reported a net loss of $144.34 million in 2025, with negative profit margins. Recent news highlights collaborations in AI and NGS services, supporting growth prospects.

Outlook remains mixed: analyst consensus is strongly bullish with 72% buy ratings and a high target of $260, but profitability challenges and high P/E of 684.85 pose risks. Cash flow stability and strategic partnerships offer upside, while margin pressures and debt levels require monitoring for sustained recovery.

Walt Disney Co

Disney (DIS) trades at $95.87, down 0.15% on the day, with strong fundamental performance including three consecutive earnings beats and improving profitability. The stock shows bearish technical signals but maintains solid analyst support with a $125.60 consensus price target representing 31% upside potential. Recent developments include Super Bowl advertising opportunities and theme park investments starting to yield returns.

Disney presents a compelling value opportunity with reasonable valuation multiples and strong cash flow generation, though facing near-term technical headwinds. Key risks include box office underperformance and regulatory challenges, while catalysts include major sporting events and streaming integration. The fundamental improvement trajectory supports the bullish analyst consensus despite current price weakness.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Charles River Laboratories Intl. Inc

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

Read more on CRL

About Walt Disney Co

The Walt Disney Company is an entertainment company with operations in media networks, park experiences & consumer products, studio entertainment and Direct-to-Consumer networks and channels. The Company serves customers worldwide.

Read more on DIS